Curis
CRIS
#10201
Rank
โ‚ฌ14.99 M
Marketcap
1,16ย โ‚ฌ
Share price
0.00%
Change (1 day)
-68.93%
Change (1 year)

Curis (CRIS) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : โ‚ฌ36.35 Million

According to Curis's latest financial reports the company's total liabilities are โ‚ฌ36.35 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Curis - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚ฌ45.41 M-12.85%
2023-12-31โ‚ฌ52.11 M-10.26%
2022-12-31โ‚ฌ58.07 M-8.13%
2021-12-31โ‚ฌ63.21 M5.52%
2020-12-31โ‚ฌ59.9 M-2.76%
2019-12-31โ‚ฌ61.61 M68.37%
2018-12-31โ‚ฌ36.59 M-11.85%
2017-12-31โ‚ฌ41.5 M53.27%
2016-12-31โ‚ฌ27.08 M-2.77%
2015-12-31โ‚ฌ27.85 M3.19%
2014-12-31โ‚ฌ26.99 M5.26%
2013-12-31โ‚ฌ25.64 M-4.44%
2012-12-31โ‚ฌ26.83 M319.71%
2011-12-31โ‚ฌ6.39 M65.75%
2010-12-31โ‚ฌ3.85 M81.4%
2009-12-31โ‚ฌ2.12 M7.83%
2008-12-31โ‚ฌ1.97 M-58.7%
2007-12-31โ‚ฌ4.77 M-61.51%
2006-12-31โ‚ฌ12.4 M-35.86%
2005-12-31โ‚ฌ19.34 M37.96%
2004-12-31โ‚ฌ14.02 M4.63%
2003-12-31โ‚ฌ13.4 M-68.09%
2002-12-31โ‚ฌ41.99 M-15.2%
2001-12-31โ‚ฌ49.52 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Exelixis
EXEL
โ‚ฌ0.56 B 1,465.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚ฌ0.75 B 1,975.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
โ‚ฌ69.45 M 91.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚ฌ43.01 M 18.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ99.31 B 273,062.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ67.24 B 184,840.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
โ‚ฌ11.43 M-68.55%๐Ÿ‡บ๐Ÿ‡ธ USA